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Background: 
 
Data are lacking on the efficacy and safety of a loading dose
of clopidogrel in the elderly
 
 
 
with acute myocardial infraction (AMI).
 
Aim:
 
 To determine 30-day and one-year mortality, as well as in-hospital
bleeding risk in elderly patients with AMI according to the use of a loading
dose of clopidogrel (
 
≥
 
 300 mg).
 
Methods: 
 
FAST-MI is a nationwide registry carried out over a 1-month
period in 2005, including consecutive patients with AMI admitted to ICUs <
48 hours from symptom onset in 223 participating centers. We assessed impact
of clopidogrel loading dose on bleeding, the need for blood transfusion and
12-month survival in elderly patients (aged 
 
≥
 
 75 years). 
 
Results: 
 
791 elderly patients were included (Mean age 81 ± 4 years, 48 %
women; 35% STEMI). 59% (466 patients) have received a clopidogrel loading
dose (
 
≥
 
 300mg).
 
 
 
Follow up was > 98% complete. Major bleeding and blood
transfusions were not significantly different in patients having received a
loading dose of clopidogrel or a conventional 75 mg dose, respectively 3.7 vs.
3.2 (p>0,05) and 6.2 vs. 5.4 (p>0,05). Early and one-year mortality were also
not significantly different. Using multivariate analyses: Clopidogrel loading
dose was not associated with a significant increase major bleeding or transfu-
sion (OR=1.09; 95%CI:0.50-2.40, p=0.82); and 12-month mortality (OR=0.95;
95%CI:0.65-1.29, p=0.61).
 
Conclusion: 
 
The present data show that in elderly patients admitted for AMI,
use of a loading dose of clopidogrel was not associated with increased in-hospital
bleeding, need for transfusion, or mortality. These results persisted after muti-
variate adjustment. Large-scale randomized trials are still needed to identify the
optimal loading dose of clopidogrel for elderly patients admitted for AMI.
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Background: 
 
It has been suggested that delays, quality and outcome of
reperfusion therapy provided to ST-Elevation Myocardial Infarction (STEMI)
patients during OFF-hours (nights and weekend) are worse than during ON-
hours (day working hours).
 
Methods: 
 
We studied 736 consecutive STEMI patients transferred for pri-
mary percutaneous intervention (PCI) to a single large volume urban Primary
PCI center. Characteristics and clinical outcome of patients admitted during
ON-hours (Monday through Friday 8 am-6 pm) were compared to OFF-hours
patients (admitted during night shifts and weekends). Clinical outcome was 1
year death and death or MI. 
 
Results: 
 
STEMI patients undergoing primary PCI were admitted more fre-
quently during OFF-hours (n=449; 61.1%) than ON-hours (n=287; 38.9%), with
no major differences in characteristics or treatment between the two groups. Use
of radial approach and the rate of stenting during PCI was 83.3% and 86.1% in
ON-hours patients vs. 88.2%.and 88.1% in OFF-hours patients. There was no
impact of time of admission on in-hospital mortality before or after adjustment for
baseline characteristics OR 1.54; CI [0.71-3.35]. Time from symptom onset to first
medical contact was shorter during OFF-hours than ON-hours (105 min [50-225]
vs. 114 min [60-367]; p=0.06). Time from first medical contact to sheath insertion
was also identical between the 2 groups (101 min [80-155] and 105 min [78-155];
p=0.61 respectively). Time to TIMI 3 flow and duration of procedure were also
similar. At one year, all cause mortality and the composite end point of death or
MI was 8.3% and 12.2% for OFF-hours patients vs. 7.0% and 10,8% in ON-hours
patients, p=0.4 and p=0.3 respectively. 
 
 
Conclusion: 
 
In a well-organized urban STEMI network, were 61% of patients
referred for primary PCI are admitted during “OFF” hours, admission time does
not impact quality of care or outcomes.
 
006
 
No reflow after primary percutaneous coronary angioplasty in ST ele-
vation myocardial infarction : incidence and risk factors
 
Fathia Mghaieth (1), Nadim Khadher (1), Sami Mourali (2), Abdeljelil
Farhati (2), Kéchida Zohra (1), Salem Abdessalem (2), Rafik Boussaada
(2), Rachid Mechmèche (2)
(1) Hôpital la Rabta, Cardiologie, Tunis, Tunisie – (2) Hôpital la Rabta,
Tunis, Tunisie
After urgent percutaneous coronary intervention (PCI) in ST elevation
myocardial infarction (STEMI), a sizable proportion of patients achieve epi-
cardial but not myocardial reperfusion. This condition known as no reflow
phenomenon is associated with a worse prognosis. 
 
Aim:
 
 to determine the incidence and clinical and angiographic risk factors of
No reflow. Population, methods and results: Our cohort included 900 consecu-
tive patients with STEMI (mean age 59.2+/- 13.3 years, 87.7% males) referred
to our service for primary or rescue PCI. Patients presented with anterior myo-
cardial infarction in 62.2% of cases, cardiovascular risk factors were: smoking:
87.7%, diabetes:31.1%, hypertension: 37.7% and dyslipidemia: 20%. Patients
had an intinial TIMI flow = 0 before the procedure in 90.1% of cases and they
achieve a TIMI 3 flow after PCI in 65.5% of cases. No reflow phenomenon
occured in 24.4% of patients and were associated to poorer in hospital prognosis
with more frequent major cardiovascular events (cardiac insufficiency, choc, re-
infarction and death) (17.6% vs 6.1%, p<0.01). Identified independant predictor
factors of no reflow phenomenon were final TIMI flow inferior to 3 (68.2 vs
22.1% p<0.01, RR=3.6), presence of multiple thrombus fragments or thrombus
in front of the culpurite lesion (65.1% vs 31%, p<0.01, RR=2.9) and longer
delay to intervention (11.5+/-6.1 vs 7.7+/-5.7 hours, RR=1.8). Thromboaspira-
tion was the only therapeutic measure reducing the risk of no reflow phenom-
enon in this cohort (16.3% vs 35.8%, p<0.01).
Death or MI after one year of follow-up
